How Cholinesterase Inhibitors Work
Cholinesterase inhibitors function by boosting the levels of acetylcholine in the brain, although they employ varying mechanisms. Some of these medications achieve this by inhibiting an enzyme responsible for breaking down acetylcholine. Alternatively, certain cholinesterase inhibitors work by targeting two enzymes for inhibition. Additionally, another drug in this class prevents the breakdown of acetylcholine while also stimulating the brain to produce more. However, as Alzheimer’s disease advances, the availability of acetylcholine diminishes, leading to a decrease in the effectiveness of these medications.
Miscellaneous Treatments
Groundbreaking Advancement: FDA Approves First Alzheimer’s Treatment Drug in Nearly Two Decades
In a remarkable breakthrough, the Food and Drug Administration (FDA) has recently given its stamp of approval to a new Alzheimer’s treatment drug. This momentous event marks the first medication to be authorized for the management of the disease in over 18 years. Unlike previous therapies that solely focused on alleviating symptoms, this groundbreaking treatment is capable of slowing down the progression of Alzheimer’s.
The key mechanism of action lies in the gradual elimination of amyloid protein, the abnormal buildup of which leads to the formation of plaques. These plaques disrupt normal brain function in individuals with Alzheimer’s. Although this drug does not have the ability to reverse the disease’s progression, it offers a glimmer of hope by effectively impeding its advancement.